CORRECT: Tissue Regenix Hires NuPak Medical Founder As New CFO

(Correcting name and headquarters location of Aperion Biologics.) Tissue Regenix Group PLC - ...

Alliance News 22 January, 2021 | 11:19AM
Email Form Facebook Twitter LinkedIn RSS

(Correcting name and headquarters location of Aperion Biologics.)

Tissue Regenix Group PLC - Leeds-based medical devices for regenerative medicine - Hires David Cocke as chief financial officer and board director. Cocke founded NuPak Medical Ltd, a contract manufacturer of sterile disposable medical devices, back in 1997. NuPak was acquired by Katena Products Inc in 2017. Cocke also was CFO of San Antonio, Texas-based Aperion Biologics Inc. He starts at Tissue Regenix immediately.

Current stock price: 0.51 pence

Year-to-date change: down 5.6%

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Tissue Regenix Group PLC 7.25 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures